We have a strong track record in product development for complex Genomic Applications, e.g., GeneSpring and MassProfiler Pro, for Agilent and Strand NGS. We extend our software development services to US-based large diagnostics, instrument, and reagent companies. We are an Illumina ICA implementation partner and have similar relationships with Agilent as well as a large pharma and diagnostics company, to name only 3 of our notable clientele. 

We have deep experience building and validating algorithms and software accompanying NGS assays, including generating hand-crafted test cases and clinical-grade documentation.

We leverage our expertise in secondary and tertiary NGS software to build custom tools to empower our India clinical diagnostics business.

• StrandNGS is our integrated platform for NGS secondary analysis, management, and visualization
• StrandOMICS is our HIPAA-compliant platform for variant classification and interpretation, thus powering NGS tertiary analysis. 

Together, Strand NGS and StrandOmics enable secondary analysis and variant reporting from somatic, inherited cancer risk and rare disease exome panels spanning ≈10,000 tests per annum.